Who we work with

We know the Microbiome is important to our clients, which include

Testimonials

SeqBiome provides excellent technical and scientific services from sample processing to the analysis of sequencing data. The whole team is very professional, reliable and supportive and we enjoy the fast (and always friendly) communication. We are pleased to have SeqBiome as a partner for high quality microbiome analysis and are looking forward to continue our excellent collaboration.

Weleda AG

Very friendly, reliable and supportive team to interact with. I’m 100% satisfied with their service

AO Research Institute Davos

The SeqBiome team were wonderful in setting up and transferring a customised bioinformatic pipeline to my team that has saved us months of project time

Prof Liam O’Mahony, UCC

It was a pleasure to work with the SeqBiome team, and their flexibility and broad technical knowledge was a huge benefit for us in designing a workplan which was tailored to our exact needs. We are confident that we have a reliable, high-quality report suitable for review by regulatory authorities and partners

PrecisionBiotics Global

We engaged Seqbiome because they could provide tailor made solutions for microbiome sequence analysis that could advance our knowledge on potential bacterial strain application. Seqbiome delivered on their promise to offer us a high quality interactive service with clear interpretable data reporting for immediate business application. We look forward to a continuous partnership with Seqbiome

H&H Group

The demand for high-quality microbiome analysis from our clients has increased dramatically in recent years. We are excited to have formed a strategic partnership with SeqBiome who complement our services in a significant way. The SeqBiome team are recognised across the globe as some of the most experienced scientists in their field. We are very much looking forward to working and scaling with them in this fast growing market.

Atlantia Clinical Food Trials

News & Insights - Highlights

SeqBiome sponsors Boston conference

November 10, 2023

Our CEO Marcus Claesson is giving a talk about his group’s research on the gut microbiome and inflammatory bowel disease at the Microbiome Data Congress at the Convene conference center in Boston on the 13th Nov. SeqBiome is proud to be one of the sponsors of the event.

Our CTO discusses microbiome and performance with Real Madrid

September 6, 2023At the 1^st International Seminar on Nutrition and Sport for Abbott-Nutrition and Real-Madrid CF, our CTO Paul Cotter spoke about the Elite Athlete Gut Microbiota. The scientific and medical teams at Abbott and Real Madrid’s are working together to push the limits across key topics including recovery, hydration, nutrition and performance to allow athletes of all skill levels to reach their full potential. You can watch the full presentation here.

Our partner Freya Biosciences announces positive microbiome therapy for vaginal dysbiosis

June 26, 2023

We are delighted to have contributed to the positive outcomes from the Freya Bioscience’s first Phase 1 clinical study of its lead asset FB101, which is an investigational immunotherapeutic targeting vaginal microbial dysbiosis. Together also with Atlantia Clinical Trials, we evaluated the longitudinal change in the vaginal microbiome after vaginal administration of FB101 in women with asymptomatic vaginal tract dysbiosis, and found that FB101 let to a rapid and sustained switch from a dysbiotic to a Lactobacillus-dominated microbiome. Half of the women showed that engraftment of the Lactobacilli species was established, as determined by strain-level engraftment analysis. Freya intends to expand studies of FB101 for improving fertility outcomes and enhancing the success rates of IVF.